top of page

ABOUT THIS PROGRAM

​

  • This Program is doctor supervised. Each participant has a follow-up visit with the supervising doctor on a bi-weekly basis. During these doctor-patient encounters, patients will answer questions regarding their overall health, their adherence to the diet, and any struggles or challenges they may be experiencing. Participants are then given a body composition analysis. Based on all of this information, participants are then given detailed information and instruction as it pertains to what they need to do for the upcoming weeks.

  • All patients are prescreened for complicating factors, poor prognostic indicators, and contraindication. If the screening reveals a complicating factor or poor prognostic indicator, a doctor will discuss the concern with the potential participant.

  • Depending on the severity of the projected clinical implications of the complicating factor or poor prognostic indicator, a person may be prohibited from undergoing the program.

  • If a potential participant’s past medical history contains any contraindications, the participant is prohibited from undergoing the program.

  • This program is based on a low glycemic index and anti-inflammatory (LGAI) diet.

  • This program includes the consumption of complex carbohydrates and is not a “protein-only” program. Complex carbohydrates prevent excessive ketosis, hyperuricemia, diuresis, electrolyte loss, re-feeding edema, and they may improve muscular endurance.

  • While undergoing the six-week program, the participant consumes between twenty-four and thirty ounces of nutrient-dense low glycemic index and anti-inflammatory foods per day.

  • The nutritional support formula is specifically developed to aid in fatty acid metabolism, suppressing hunger and cravings, stabilizing blood sugar, and in the mild detoxification of the body.

  • The program is six weeks in duration and falls well within the accepted standards for very low calorie diets (VLCDs), as established by scientific data. These parameters include: doctor supervision, time on VLCD, dietary modifications, behavioral modifications, nutritional supplementation, and, when indicated, exercise.

  • The program provides a “re-feeding” component during which participants transition back to a “normal” diet composed of LGAI foods.

  • Participants are provided with guidelines, strategies, and tools to help them increase their chances of long-term weight loss success. These tools are based on each patient’s BMR, activity level, appropriate exercise, and continued healthy nutritional consumption.

​

Research:

VLCD & Diabetes

 

American Diabetes Association

Benefits Of VLCD Outweigh Risks In NIDDM:

http://care.diabetesjournals.org/content/14/9/802.short
American Diabetes Association

Normalized Hypothalamic Response To Glucose Consumption:

http://diabetes.diabetesjournals.org/content/61/12/3255.abstract
diabetes.co.uk

Benefits For Obese Diabetics

http://www.diabetes.co.uk/news/2011/Nov/very-low-calorie-diet-benefits-for-obese-diabetics-98027975.html
American Diabetes Association

Adolescents Type 2 Diabetics and VLCD:

http://care.diabetesjournals.org/content/27/2/348.full
American Diabetes Association

Benefits in Obese NIDDM:

http://www.ncbi.nlm.nih.gov/pubmed/1959474
Diabetes Research & Clinical Practice

Improved Glomerular Filtration:

http://www.ncbi.nlm.nih.gov/pubmed/9229194

Efficacy/History/Safety of VLCD

International Journal of Obesity

Development, Efficacy and Safety of VLCD:

http://www.ncbi.nlm.nih.gov/pubmed/7024153
Nutrition & Diabetes Journal

Safety & Efficacy In Pre-Diabetic, Diabetic, and NormoglycemicPatients:

http://www.ncbi.nlm.nih.gov/pubmed/24513578
International Journal of Obesity

Analysis of VLCD Outcomes:

http://www.ncbi.nlm.nih.gov/pubmed/15711602
Nutrition Journal

Improved Metabolic Control:

http://www.ncbi.nlm.nih.gov/pubmed/25069603

Miscellaneous Studies

Journal Of Diabetes & Metabolism

Improved Renal Function:

http://www.ncbi.nlm.nih.gov/pubmed/24439268
Am Journal of Gastroenterology

VLCD Before Gastric Bypass:

http://www.ncbi.nlm.nih.gov/pubmed/1728126

bottom of page